1. Comparative pharmacokinetics and bioavailability of two tylosin formulations in chickens after oral administration;Abu-Basha;J. Hell. Vet.,2012
2. Determination of mean residence time of drug in plasma and the influence of the initial drug elimination and distribution on the calculation of pharmacokinetic parameters;Berezhkovskiy;J. Pharmaceut. Sci.,2009
3. Pharmacokinetic profiles of florfenicol in spotted halibut, Verasper variegatus, at two water temperatures;Chang;J. Vet. Pharm. Ther.,2019
4. CVMP, 2002. Tylosin (Extension to All Food Producing Species). Summary Report (5). EMEA/MRL/829/02-Final. European Agency for the Evaluation of Medicinal Products, London, UK. Available online: 〈https://www.ema.europa.eu/en/documents/mrl-report/tylosin-extension-all-food-producing-species-summary-report-5-committee-veterinary-medicinal_en.pdf〉, (Accessed 28 July 2021).
5. CVMP, EMEA, 1996. Note for Guidance: Approach Towards Harmonisation of Withdrawal Periods. Committee for Veterinary Medicinal Products and the European Agency for the Evaluation of Medicinal Products. EMEA/CVMP/036/95-Final, London, UK.